Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of the extract of the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2025, as published in "Business Standard" and "Makkal Kural" on November 13, 2025.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has informed the stock exchange that it has published the extract of its unaudited financial results for the quarter and half year ended September 30, 2025, in two newspapers — Business Standard (English) and Makkal Kural (Tamil) — on November 13, 2025. This is a routine regulatory filing required by SEBI, where companies are mandated to publish a summary of their quarterly results in newspapers for wider public access. The actual detailed financial numbers would have been filed separately with the exchange as part of the results submission.
This is purely a procedural compliance announcement with no new financial or strategic information for shareholders. The detailed Q2/H1 FY26 results should be referred to in the company's earlier results filing for any meaningful investment insight.